Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123942014 | 12394201 | 4 | F | 201402 | 20160706 | 20160523 | 20160713 | EXP | FR-PFIZER INC-2016267218 | PFIZER | 68.00 | YR | F | Y | 50.00000 | KG | 20160713 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123942014 | 12394201 | 1 | PS | Imeth | METHOTREXATE SODIUM | 1 | Oral | 2.5 MG, (3 DOSAGE FORM, 1 IN 1 W) | Y | 11719 | 7.5 | MG | TABLET | /wk | |||||
| 123942014 | 12394201 | 2 | SS | NOVATREX NOS | AZITHROMYCIN OR METHOTREXATE SODIUM | 1 | Oral | 4 DF, WEEKLY (1 IN 1 W) | 1256 | DF | Y | 11719 | 4 | DF | TABLET | /wk | |||
| 123942014 | 12394201 | 3 | SS | PREDNISONE. | PREDNISONE | 1 | 10 MG, DAILY | Y | 0 | 10 | MG | ||||||||
| 123942014 | 12394201 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 40 MG, DAILY | Y | 0 | 40 | MG | |||||||
| 123942014 | 12394201 | 5 | SS | PREDNISONE. | PREDNISONE | 1 | 15 MG, DAILY (MORNING) | Y | 0 | 15 | MG | ||||||||
| 123942014 | 12394201 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | 13 MG, DAILY | Y | 0 | 13 | MG | ||||||||
| 123942014 | 12394201 | 7 | SS | MABTHERA | RITUXIMAB | 1 | 1000 MG, DAY 1 AND DAY 3 | Y | 0 | 1000 | MG | ||||||||
| 123942014 | 12394201 | 8 | SS | MABTHERA | RITUXIMAB | 1 | Parenteral | 1 G ONCE EVERY 15 DAYS | Y | 0 | 1 | G | |||||||
| 123942014 | 12394201 | 9 | C | PREVISCAN | FLUINDIONE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 123942014 | 12394201 | 10 | C | KARDEGIC | ASPIRIN LYSINE | 1 | UNK | 0 | |||||||||||
| 123942014 | 12394201 | 11 | C | INEXIUM | ESOMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 123942014 | 12394201 | 12 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | UNK | 0 | |||||||||||
| 123942014 | 12394201 | 13 | C | CALCIDOSE | CALCIUM CARBONATE | 1 | UNK | 0 | |||||||||||
| 123942014 | 12394201 | 14 | C | DOLIPRANE | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 123942014 | 12394201 | 15 | C | SERESTA | OXAZEPAM | 1 | UNK | 0 | |||||||||||
| 123942014 | 12394201 | 16 | C | FORSTEO | TERIPARATIDE | 1 | Subcutaneous | 20 MICROGRAMS/80 MICROLITRES (1 DOSAGE FORM,1 D) | 0 | 1 | DF | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 123942014 | 12394201 | 17 | C | FOLIC ACID. | FOLIC ACID | 1 | 5 MG, WEEKLY | 0 | 5 | MG | /wk | ||||||||
| 123942014 | 12394201 | 18 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | 20 MG, DAILY | 0 | 20 | MG | |||||||||
| 123942014 | 12394201 | 19 | C | CACIT D3 | CALCIUMCHOLECALCIFEROL | 1 | 500 MG, 2X/DAY (IN THE MORNING) | 0 | 500 | MG | BID | ||||||||
| 123942014 | 12394201 | 20 | C | HUMAN INSULIN | INSULIN HUMAN | 1 | 7 IU, DAILY IN THE MORNING | 0 | 7 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123942014 | 12394201 | 1 | Polyarteritis nodosa |
| 123942014 | 12394201 | 2 | Polyarteritis nodosa |
| 123942014 | 12394201 | 3 | Polyarteritis nodosa |
| 123942014 | 12394201 | 7 | Polyarteritis nodosa |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123942014 | 12394201 | OT |
| 123942014 | 12394201 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123942014 | 12394201 | Arthritis bacterial | |
| 123942014 | 12394201 | Bronchitis | |
| 123942014 | 12394201 | Condition aggravated | |
| 123942014 | 12394201 | Enterobacter sepsis | |
| 123942014 | 12394201 | Hypogammaglobulinaemia | |
| 123942014 | 12394201 | Immunodeficiency | |
| 123942014 | 12394201 | Product use issue | |
| 123942014 | 12394201 | Secondary immunodeficiency | |
| 123942014 | 12394201 | Urosepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123942014 | 12394201 | 1 | 20140326 | 2014 | 0 | |
| 123942014 | 12394201 | 2 | 2008 | 20140326 | 0 | |
| 123942014 | 12394201 | 4 | 2008 | 0 | ||
| 123942014 | 12394201 | 6 | 20160204 | 0 | ||
| 123942014 | 12394201 | 7 | 201310 | 0 | ||
| 123942014 | 12394201 | 8 | 20131027 | 20140521 | 0 | |
| 123942014 | 12394201 | 16 | 20140211 | 0 |